Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Jiang W, Su J, Zhang X, Cheng X, Zhou J, Shi R, Zhang H.

Inflamm Res. 2014 Nov;63(11):943-50. doi: 10.1007/s00011-014-0768-7.

PMID:
25129403
2.

Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.

Beltrán CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, Quera R, Hermoso MA.

Eur Cytokine Netw. 2009 Mar;20(1):33-8. doi: 10.1684/ecn.2009.0142. Erratum in: Eur Cytokine Netw. 2009 Jun;20(2):94.

3.

Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.

Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J, Tillack-Schreiber C, Schnitzler F, Beigel F, Brand S.

Inflamm Bowel Dis. 2015 Oct;21(10):2327-40. doi: 10.1097/MIB.0000000000000515.

PMID:
26263469
4.

TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.

Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J.

Cytokine. 2011 Dec;56(3):633-40. doi: 10.1016/j.cyto.2011.08.036.

PMID:
21945121
5.

Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.

Nielsen OH, Kirman I, Rüdiger N, Hendel J, Vainer B.

Scand J Gastroenterol. 2003 Feb;38(2):180-5.

PMID:
12678335
6.

The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.

Li Y, Wang Y, Liu Y, Wang Y, Zuo X, Li Y, Lu X.

Mediators Inflamm. 2014;2014:136329. doi: 10.1155/2014/136329.

7.

Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.

Shen W, Durum SK.

Neurochem Res. 2010 Jun;35(6):940-6. doi: 10.1007/s11064-009-0091-9. Review.

PMID:
19915978
8.

Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.

Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S.

Inflamm Bowel Dis. 2013 Nov;19(12):2522-34. doi: 10.1097/MIB.0b013e3182a85709.

PMID:
24097227
9.

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.

Hovhannisyan Z, Treatman J, Littman DR, Mayer L.

Gastroenterology. 2011 Mar;140(3):957-65. doi: 10.1053/j.gastro.2010.12.002.

10.

Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.

Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, Chatelain D, Barre A, Nguyen-Khac E, Lantz O, Dupas JL, Treiner E.

Clin Exp Immunol. 2014 May;176(2):266-74. doi: 10.1111/cei.12277.

11.

The role of the novel Th17 cytokine IL-26 in intestinal inflammation.

Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S.

Gut. 2009 Sep;58(9):1207-17. doi: 10.1136/gut.2007.130112.

PMID:
18483078
12.

Increased expression of interleukin 17 in inflammatory bowel disease.

Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y.

Gut. 2003 Jan;52(1):65-70.

13.

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.

Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A, Göke B, Ochsenkühn T, Müller-Myhsok B, Lohse P, Brand S.

Inflamm Bowel Dis. 2008 Apr;14(4):437-45.

PMID:
18088064
14.

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

Kucharzik T, Stoll R, Lügering N, Domschke W.

Clin Exp Immunol. 1995 Jun;100(3):452-6.

15.

Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.

Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A.

Inflamm Bowel Dis. 2005 Jan;11(1):16-23.

PMID:
15674109
16.

The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.

Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, Lin H, Yu J, Qian J, Yang PC, Wang X.

J Leukoc Biol. 2011 Apr;89(4):597-606. doi: 10.1189/jlb.0810456.

PMID:
21227898
17.

Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

Veny M, Esteller M, Ricart E, Piqué JM, Panés J, Salas A.

Aliment Pharmacol Ther. 2010 Mar;31(5):561-72. doi: 10.1111/j.1365-2036.2009.04209.x.

18.

Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.

Iboshi Y, Nakamura K, Ihara E, Iwasa T, Akiho H, Harada N, Nakamuta M, Takayanagi R.

Inflamm Bowel Dis. 2014 Jun;20(6):967-77. doi: 10.1097/MIB.0000000000000028.

PMID:
24739631
19.

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Sugihara T, Kobori A, Imaeda H, Tsujikawa T, Amagase K, Takeuchi K, Fujiyama Y, Andoh A.

Clin Exp Immunol. 2010 Jun;160(3):386-93. doi: 10.1111/j.1365-2249.2010.04093.x.

20.

Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease.

Dige A, Støy S, Rasmussen TK, Kelsen J, Hvas CL, Sandahl TD, Dahlerup JF, Deleuran B, Agnholt J.

J Crohns Colitis. 2013 Apr;7(3):248-55. doi: 10.1016/j.crohns.2012.06.015.

PMID:
22784949
Items per page

Supplemental Content

Support Center